Orgenesis Inc (ORGS)
0.5486
+0.02
(+3.31%)
USD |
NASDAQ |
May 17, 16:00
0.5486
0.00 (0.00%)
After-Hours: 20:00
Orgenesis Enterprise Value: 39.69M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 39.69M |
| May 15, 2024 | 40.88M |
| May 14, 2024 | 42.22M |
| May 13, 2024 | 42.37M |
| May 10, 2024 | 41.38M |
| May 09, 2024 | 40.48M |
| May 08, 2024 | 39.31M |
| May 07, 2024 | 39.67M |
| May 06, 2024 | 39.31M |
| May 03, 2024 | 39.56M |
| May 02, 2024 | 40.10M |
| May 01, 2024 | 39.51M |
| April 30, 2024 | 38.81M |
| April 29, 2024 | 38.63M |
| April 26, 2024 | 38.87M |
| April 25, 2024 | 38.77M |
| April 24, 2024 | 38.70M |
| April 23, 2024 | 39.28M |
| April 22, 2024 | 38.88M |
| April 19, 2024 | 38.65M |
| April 18, 2024 | 39.03M |
| April 17, 2024 | 38.92M |
| April 16, 2024 | 38.62M |
| April 15, 2024 | 38.61M |
| April 12, 2024 | 38.29M |
| Date | Value |
|---|---|
| April 11, 2024 | 40.56M |
| April 10, 2024 | 39.34M |
| April 09, 2024 | 38.01M |
| April 08, 2024 | 37.67M |
| April 05, 2024 | 39.17M |
| April 04, 2024 | 41.26M |
| April 03, 2024 | 38.36M |
| April 02, 2024 | 34.65M |
| April 01, 2024 | 41.29M |
| March 28, 2024 | 49.52M |
| March 27, 2024 | 50.48M |
| March 26, 2024 | 50.51M |
| March 25, 2024 | 52.15M |
| March 22, 2024 | 52.15M |
| March 21, 2024 | 51.16M |
| March 20, 2024 | 52.18M |
| March 19, 2024 | 51.50M |
| March 18, 2024 | 51.37M |
| March 15, 2024 | 48.40M |
| March 14, 2024 | 47.95M |
| March 13, 2024 | 51.93M |
| March 12, 2024 | 50.82M |
| March 11, 2024 | 49.51M |
| March 08, 2024 | 50.73M |
| March 07, 2024 | 50.10M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-29.66M
Minimum
Apr 01 2020
162.08M
Maximum
Mar 12 2021
68.55M
Average
67.62M
Median
Aug 27 2019
Enterprise Value Benchmarks
| Altimmune Inc | 449.01M |
| Verastem Inc | 259.27M |
| Oragenics Inc | 5.770M |
| Actinium Pharmaceuticals Inc | 209.31M |
| Dare Bioscience Inc | 33.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.623M |
| Revenue (Quarterly) | 0.165M |
| Total Expenses (Quarterly) | 5.467M |
| EPS Diluted (Quarterly) | -0.21 |
| Gross Profit Margin (Quarterly) | 1.82% |
| Profit Margin (Quarterly) | -4.01K% |
| Earnings Yield | -357.3% |
| Normalized Earnings Yield | -322.82 |